Roxana Mehran

2.6k total papers · 153.1k total citations
1.3k papers, 75.8k citations indexed

About

Roxana Mehran is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roxana Mehran has authored 1.3k papers receiving a total of 75.8k indexed citations (citations by other indexed papers that have themselves been cited), including 930 papers in Cardiology and Cardiovascular Medicine, 782 papers in Surgery and 388 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roxana Mehran's work include Coronary Interventions and Diagnostics (674 papers), Acute Myocardial Infarction Research (578 papers) and Cardiac Imaging and Diagnostics (377 papers). Roxana Mehran is often cited by papers focused on Coronary Interventions and Diagnostics (674 papers), Acute Myocardial Infarction Research (578 papers) and Cardiac Imaging and Diagnostics (377 papers). Roxana Mehran collaborates with scholars based in United States, Italy and Germany. Roxana Mehran's co-authors include Gregg W. Stone, Alexandra J. Lansky, George Dangas, Martin B. Leon, Gary S. Mintz, Eugenia Nikolsky, Jeffrey W. Moses, Martin Fahy, Donald E. Cutlip and Pascal Vranckx and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Roxana Mehran

1.2k papers receiving 73.6k citations

Hit Papers

Clinical End Points in Co... 1999 2026 2008 2017 2007 2011 2011 2011 2004 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical End Points in Coronary Stent Trials
    2007 4.2k citations Donald E. Cutlip, Stephan Windecker et al. Circulation profile →
  2. Standardized Bleeding Definitions for Cardiovascular Clinical Trials
    2011 2.9k citations Roxana Mehran, Sunil V. Rao et al. Circulation profile →
  3. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
    2011 2.4k citations Glenn N. Levine, Eric Bates et al. Circulation profile →
  4. A Prospective Natural-History Study of Coronary Atherosclerosis
    2011 2.1k citations Gregg W. Stone, Akiko Maehara et al. New England Journal of Medicine profile →
  5. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention
    2004 1.6k citations Roxana Mehran, Eve Aymong et al. Journal of the American College of Cardiology profile →
  6. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
    2011 1.5k citations Glenn N. Levine, Eric Bates et al. Journal of the American College of Cardiology profile →
  7. Bivalirudin during Primary PCI in Acute Myocardial Infarction
    2008 1.2k citations Gregg W. Stone, Bernhard Witzenbichler et al. New England Journal of Medicine profile →
  8. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
    2007 1.2k citations Gregg W. Stone, Jeffrey W. Moses et al. New England Journal of Medicine profile →
  9. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
    2016 1.0k citations Glenn N. Levine, Eric Bates et al. Journal of the American College of Cardiology profile →
  10. Angiographic Patterns of In-Stent Restenosis
    1999 983 citations Roxana Mehran, George Dangas et al. Circulation profile →
  11. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
    2016 937 citations C. Michael Gibson, Roxana Mehran et al. New England Journal of Medicine profile →
  12. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
    2011 895 citations M.B. Leon, Nicolò Piazza et al. European Heart Journal profile →
  13. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary interventionDevelopment and initial validation
    2004 891 citations Roxana Mehran, Eve Aymong et al. Journal of the American College of Cardiology profile →
  14. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
    2016 883 citations Glenn N. Levine, Eric Bates et al. Circulation profile →
  15. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
    2016 848 citations Amit V. Khera, Connor A. Emdin et al. New England Journal of Medicine profile →
  16. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
    2021 736 citations Birgit Vogel, C. Noel Bairey Merz et al. The Lancet profile →
  17. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk
    2006 653 citations Roxana Mehran, Eugenia Nikolsky Kidney International profile →
  18. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
    2013 611 citations Gregg W. Stone, Bernhard Witzenbichler et al. The Lancet profile →
  19. Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes
    2007 603 citations Steven V. Manoukian, Frederick Feit et al. Journal of the American College of Cardiology profile →
  20. In-Stent Restenosis in the Drug-Eluting Stent Era
    2010 587 citations George Dangas, Bimmer E. Claessen et al. Journal of the American College of Cardiology profile →
  21. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
    2000 577 citations Luis Gruberg, Gary S. Mintz et al. Journal of the American College of Cardiology profile →
  22. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation
    2005 563 citations Kenichi Fujii, Stéphane Carlier et al. Journal of the American College of Cardiology profile →
  23. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials
    2011 540 citations Martin B. Leon, Nicolò Piazza et al. Journal of the American College of Cardiology profile →
  24. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
    2018 502 citations Eugène McFadden, Andrew Farb et al. Circulation profile →
  25. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
    2014 500 citations James E. Tcheng, Donald E. Cutlip et al. Circulation profile →
  26. Comparison of Propensity Score Methods and Covariate Adjustment
    2017 475 citations John Gregson, Usman Baber et al. Journal of the American College of Cardiology profile →
  27. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
    2011 469 citations Glenn N. Levine, Eric Bates et al. Circulation profile →
  28. A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
    2010 443 citations Roxana Mehran, Stuart Pocock et al. Journal of the American College of Cardiology profile →
  29. Safety and Efficacy of Drug-Eluting and Bare Metal Stents
    2009 408 citations Ajay J. Kirtane, Srinivas Iyengar et al. Circulation profile →
  30. Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization
    2013 401 citations Issam Moussa, Lloyd W. Klein et al. Journal of the American College of Cardiology profile →
  31. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
    2014 376 citations James E. Tcheng, Donald E. Cutlip et al. Journal of the American College of Cardiology profile →
  32. Contrast-Associated Acute Kidney Injury
    2019 356 citations Roxana Mehran, George Dangas et al. New England Journal of Medicine profile →
  33. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions
    2015 351 citations Gregg W. Stone, David Adams et al. Journal of the American College of Cardiology profile →
  34. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
    2017 339 citations Pradeep Natarajan, Usman Baber et al. Circulation profile →
  35. Ischemic Outcomes After Coronary Intervention of Calcified Vessels in Acute Coronary Syndromes
    2014 332 citations Philippe Généreux, Mahesh V. Madhavan et al. Journal of the American College of Cardiology profile →
  36. Prosthetic Heart Valve Thrombosis
    2016 295 citations George Dangas, Jeffrey I. Weitz et al. Journal of the American College of Cardiology profile →
  37. Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults
    2015 294 citations Usman Baber, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  38. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
    2015 269 citations Philippe Généreux, Gennaro Giustino et al. Journal of the American College of Cardiology profile →
  39. 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
    2017 261 citations John W. Eikelboom, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  40. ST-segment elevation myocardial infarction
    2019 230 citations Birgit Vogel, Bimmer E. Claessen et al. profile →
  41. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
    2020 210 citations Laxmi S. Mehta, Carole A. Warnes et al. Circulation profile →
  42. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
    2020 195 citations John W. Eikelboom, Roxana Mehran et al. Journal of the American College of Cardiology profile →
  43. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention
    2020 195 citations Mahesh V. Madhavan, Ajay J. Kirtane et al. Journal of the American College of Cardiology profile →
  44. Coronary In-Stent Restenosis
    2022 173 citations Gennaro Giustino, Antonio Colombo et al. Journal of the American College of Cardiology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roxana Mehran 53.0k 42.4k 22.7k 14.3k 7.6k 1.3k 75.8k
Gregg W. Stone 63.3k 1.2× 56.7k 1.3× 31.4k 1.4× 15.8k 1.1× 6.2k 0.8× 1.6k 87.7k
David R. Holmes 63.7k 1.2× 42.0k 1.0× 25.4k 1.1× 14.0k 1.0× 3.6k 0.5× 1.4k 89.1k
Martin B. Leon 48.4k 0.9× 41.7k 1.0× 24.1k 1.1× 20.4k 1.4× 1.8k 0.2× 1.2k 72.8k
Valentı́n Fuster 53.8k 1.0× 34.0k 0.8× 22.9k 1.0× 21.3k 1.5× 6.5k 0.9× 1.3k 101.1k
Harvey D. White 45.1k 0.9× 21.7k 0.5× 14.0k 0.6× 4.2k 0.3× 5.8k 0.8× 720 58.0k
Alexandra J. Lansky 27.6k 0.5× 29.3k 0.7× 17.5k 0.8× 10.1k 0.7× 2.6k 0.3× 621 42.5k
Philippe Gabríel Steg 56.3k 1.1× 30.0k 0.7× 10.3k 0.5× 9.8k 0.7× 9.5k 1.3× 1.1k 76.9k
Bernard J. Gersh 61.6k 1.2× 19.1k 0.5× 13.7k 0.6× 6.8k 0.5× 5.1k 0.7× 1.1k 76.3k
Antonio Colombo 38.8k 0.7× 39.7k 0.9× 20.4k 0.9× 13.9k 1.0× 1.6k 0.2× 1.3k 55.4k
Eric D. Peterson 46.8k 0.9× 21.4k 0.5× 8.0k 0.4× 9.7k 0.7× 6.2k 0.8× 1.2k 79.4k

Countries citing papers authored by Roxana Mehran

Since Specialization
Citations

This map shows the geographic impact of Roxana Mehran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Mehran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Mehran more than expected).

Fields of papers citing papers by Roxana Mehran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Mehran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Mehran. The network helps show where Roxana Mehran may publish in the future.

Co-authorship network of co-authors of Roxana Mehran

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana Mehran. A scholar is included among the top collaborators of Roxana Mehran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana Mehran. Roxana Mehran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Duncan Breakdown of academic impact, for papers by Ioan Pop Breakdown of academic impact, for papers by Markus W. Büchler Breakdown of academic impact, for papers by J. Fraser Stoddart Breakdown of academic impact, for papers by M. Hassan Murad Breakdown of academic impact, for papers by Melanie J. Davies Breakdown of academic impact, for papers by Alisdair R. Fernie Breakdown of academic impact, for papers by Maurizio Fava
Rankless by CCL
2026